About Crimson Life SciencesFounded in 1992, Crimson is the only translation practice devoted exclusively to Class II and III devices and Class B, C, and D IVDs. Crimson is the first translation practice in the world certified to ISO 9001, ISO 13485, and ISO 14971. Crimson has received official Notified Body recognition for its innovative application of the SAE J2450 translation quality standard. The company's specialized approach to translation risk management is the basis of the world’s only labeling translation patent (U.S. Patent No. 8,140,322 B2).

Crimson's specialized approach to medical technology translation has been featured in industry publications such as Medical Device & Diagnostics Industry, BI&T Journal (AAMI publication), Orthopedic Design & Technology, and Medical Products Outsourcing.

In 2005, Crimson joined the growing TransPerfect family of companies. Now, together with TransPerfect services and Translations.com technology, Crimson forms the basis of EnCompass – content solutions for medical device manufacturers.

 

 

 

Crimson Life Sciences has become
TransPerfect Medical Device Solutions.


You will be redirected to the TransPerfect website in